CJC-1295 vs CJC-1295 with DAC, and the CJC-1295 + Ipamorelin Blend: Nomenclature Explained

Catalog terminology

Catalog nomenclature can be ambiguous because “CJC-1295” is used in more than one way across research documentation. The name identifies a 30-amino-acid modified analog, but a short catalog label alone may not specify every structural detail. A careful record distinguishes the exact wording on the vial label, the product page, and the lot-matched certificate of analysis. Those sources should be read together rather than treating a shorthand name as a complete structural description.

The phrase “with DAC” refers to a maleimidopropionyl-lysine linker modification. This addition changes the molecule’s structure and molecular weight. By contrast, “Mod GRF 1-29” is a common synonym for CJC-1295 without DAC. These naming conventions are useful for comparing written specifications, but synonyms should not replace confirmation of the exact form identified in the lot documentation.

DAC as a structural descriptor

DAC is an abbreviation for drug affinity complex. In this nomenclature context, its useful meaning is a chemical modification, not a separate peptide sequence name. The maleimidopropionyl-lysine linker is the structural feature associated with the “with DAC” designation. Records that use this wording should make clear whether they are describing the modified structure or merely repeating a broad catalog heading. Molecular weight is one practical point of comparison because a linker modification changes the molecule’s formula and mass.

A label that says only “CJC-1295” does not, by itself, establish whether DAC is present. The store’s specification for the blend lists “CJC-1295”; it does not state DAC or no-DAC. Buyers should check the vial label and the lot-matched COA for the exact form. This wording preserves the distinction between a catalog name and a verified structural identity, and avoids inferring a feature that the available label does not state.

The Ipamorelin component

Ipamorelin is a pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. Its stated molecular formula is C38H49N9O5, and its molecular weight is 711.9 g/mol. In sequence notation, Aib denotes an alpha-aminoisobutyric acid residue; the other abbreviations represent the named amino-acid components, including D-configured residues and a C-terminal amide. Recording sequence, formula, and mass together supplies several independent identifiers for technical comparison.

For a two-component preparation, the identity of each named component should remain explicit in specifications. A blend title is not a substitute for the component listing, and a component listing is not a substitute for lot-level analytical documentation. The Ipamorelin sequence and composition provide a defined reference point, while the CJC-1295 label requires the form check described above. These conventions help keep inventory records, labels, and analytical files aligned.

Blend presentation

The catalog blend contains CJC-1295 5 mg and Ipamorelin 5 mg in one vial. The amounts are product composition facts and should be represented as two separate component entries, not as a single 10 mg molecular species. A clear specification names both components, gives the amount of each, and preserves the exact CJC-1295 wording shown on the store label. The formulation is presented as a lyophilized material in a sealed glass vial.

Labels and product records should use consistent capitalization, hyphenation, and component order. Where a page shortens the blend name for space, the detailed specification should retain the full component names and the individual amounts. A lot identifier links that physical vial to its certificate of analysis and associated records. Consistency reduces ambiguity during receiving, storage, inventory review, and subsequent analytical work without relying on informal naming conventions.

Identity and analytical records

A lot-matched COA is the appropriate record to consult for the specified lot. Review its product identifier, lot number, issue date, analytical methods, and reported results as a connected record set. HPLC can characterize chromatographic purity profiles, while LC-MS can support mass-based identity assessment. Methods and acceptance criteria should be interpreted as stated in the document; a method name alone does not establish a result. Keep the COA linked to the vial’s lot identifier rather than filing it only under a general product name.

The site provides a Verify a lot page for checking whether a COA corresponds to a listed lot. Preserve the label and verification details in the receiving record so that the chain from catalog specification to vial to analytical file remains traceable. If a name is abbreviated differently across documents, record the exact text in each source and resolve discrepancies against the lot-specific record rather than silently normalizing them.

Label and record reconciliation

A structured comparison can resolve differences among abbreviated product names without silently changing source records. Capture the label wording verbatim, then transcribe the product identifier, component amounts, lot code, and document revision from the accompanying paperwork. Mark each field as confirmed, absent, or inconsistent; a blank field should not be interpreted as confirmation of a structural feature.

If a specification uses a synonym while the COA uses a catalog code, retain both expressions in the record and document the cross-reference used. Check that the vial quantity and blend components agree across the label and product specification, while keeping analytical findings attached only to the sample described in the report. A dated reconciliation note provides context for future inventory review and avoids overwriting the original evidence.

For archival consistency, preserve the original COA filename and its revision details when saving a verified copy. A filename alone is not a lot identifier, so index it alongside the code printed on the vial.

Handling and shipment records

All listed materials are lyophilized in sealed glass vials. Store them at 2–8 °C, protect them from light, and keep them dry. These conditions describe storage of the sealed lyophilized vial; follow the supplied documentation for any handling details not specified here. Record receipt date, lot identifier, package condition, and storage placement so that each vial remains associated with its paperwork.

Shipping is US-only and uses cold-chain handling. Receiving documentation can note the shipment identifier and any temperature-control materials included with the parcel. The product label, lot-matched COA, and Verify a lot page together support a consistent identity and traceability record. For this blend, the central nomenclature check remains whether the lot documentation specifies the CJC-1295 form, since the store label does not state DAC or no-DAC.